IGHMBP2 and Skeletal myopathy: However, transgenic animal lines develop cardiac and skeletal myopathy, which suggests that IGHMBP2 is involved in the maintenance of differentiated tissues, although the pathogenic mechanism for such phenotypes resulting from IGHMBP2 alteration remains unclear80.